Elder Pharmaceuticals plans to create super brand
Self-owned brands to get a major boost especially in the fields of anti-infectives, lifestyle diseases, dermatology and neurology…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
CSR: An opportunity for pharma companies
Adarsh Kataruka, Director, SoulAce Social Venture, talks about why each company needs to chart a CSR vision and work towards…
Budget 2014: Will implementation live up to intent?
I had ended my last edit with the hope that this year, unlike previous years, the pharmaceutical sector’s hopes would not be as…
‘India is crucial to us for the future’
With a 5.7 per cent growth in sales in 2013, Boehringer Ingelheim (BI) ranks seventh among its global peers but has a long way to…
Cipla plans investment in its UK subsidiary
The investment will fund the launch of a range of drugs in the areas of respiratory, oncology and antiretroviral medicines
Actavis completes acquisition of Forest Laboratories
Creates an innovative new model in speciality pharma leadership
Merck Serono’s grants programme to fund scientific innovation
The programme combines grants portfolio with annual €20 million investment to advance innovation and medical education
Bharat Biotech donates REGEN-D to victims of AP gas explosion
Donates 500 tubes of REGEN-D to AP CM’s Relief Fund
Glenmark Generics receives ANDA approval
Telmisartan is Glenmark’s generic version of Boehringer Ingelheim’s Micardis